ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR Convergence 2023

Abstract Number: 1229

Longitudinal Assessment of Self-reported Executive Function in Youth with Childhood-Onset Lupus

Tala El Tal1, justine ledochowski2, Sarah Mossad3, Victoria Lishak3, Ibrahim Mohamed4, Joanna Law3, Lawrence Ng3, Paris Moaf3, Asha Jeyanathan3, Adrienne Davis3, Linda Hiraki3, Deborah Levy3, Zahi Touma5, Natoshia Cunningham6, Ashley Danguecan3 and Andrea Knight3, 1Division of Rheumatology, The Hospital for Sick Children, andDivision of Rheumatology, Children’s Hospital of Eastern Ontario, Ottawa, ON, Canada, 2Department of Psychology, The Hospital for Sick Children, Toronto, ON, Canada, 3The Hospital for Sick Children, Toronto, ON, Canada, 4The Hospital for Sick Children, Brampton, ON, Canada, 5University of Toronto, Toronto, ON, Canada, 6Michigan State University, Grand Rapids, MI

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR Convergence 2023

Keywords: Cognitive dysfunction, longitudinal studies, Pediatric rheumatology, Systemic lupus erythematosus (SLE)

Session Information

Date: Monday, November 13, 2023

Title: (1221–1255) Pediatric Rheumatology – Clinical Poster II: Connective Tissue Disease

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Cognitive dysfunction (including executive dysfunction) affects up to 60% of youth with childhood-onset systemic lupus erythematosus (cSLE), with potential adverse effects on health-related quality of life, and medication adherence. Patients with cSLE are often diagnosed during a critical period of neurodevelopment, and changes in executive function (EF) over time have not been well-studied in cSLE compared to typically developing children. We aimed to characterize the course of EF over time in cSLE patients matched to healthy controls.

Methods: We examined a prospective longitudinal sample of patients with cSLE (ages 12-17, met ACR or SLICC classification criteria for SLE), along with age and sex-matched healthy controls over two time points (baseline and 1 year later) collected from January 2020 to May 2023. Participants completed the self-report Behavior Rating Inventory of Executive Function 2 (BRIEF-2) that generated overall EF difficulties index score (global executive composite (GEC)), and three sub-indices – behavioral regulation index (BRI), cognitive regulation index (CRI), and emotion regulation index (ERI)). T-scores are transformations of raw scores based on age and sex norms. A higher T-score indicates a greater degree of difficulty in executive functioning. Disease measures including SLE Disease Activity Index 2000 (SLEDAI-2K), SLICC/ACR damage index (SDI), glucocorticoid use at visit and cumulative use, and disease duration were collected. The primary outcome was EF measured by GEC, BRI, CRI, and ERI T-scores, with a focus on GEC. T-tests were performed to examine within-group and between-group comparisons of mean scores at baseline and 1-year, and of change in mean scores (1 year minus baseline) respectively, for cSLE participants and controls.

Results: Twenty-two patients with cSLE and 10 controls were included. For cSLE, the mean age was 15.7 ± SD 1.5 years, 86% were female, median SLEDAI-2K score was 2 (IQR 2-4) and median disease duration was 2 years (IQR 1.2-4.3) (Table1). In cSLE patients compared to controls, mildly elevated GEC T-scores were present in 18% (n=4) vs. 1 (10%); potentially and/or clinically elevated GEC T-scores were present in 41% (n=9) vs 30 %(n=3) (Table2) at baseline or 1-year timepoints. While the mean CRI T-score showed a small improvement from baseline and 1 year later (60 vs 56.1), there were no statistically significant differences for within-group comparisons of any of the BRIEF-T scores over time for both cSLE and controls (Table 2). There were also no significant differences between the cSLE and control groups for mean change in the BRIEF-T scores over time (GEC, t-value=0.78, p=0.43; BRI t-value= -0.28, p=0.77, CRI t-value= -1.2, p=0.20, ERI t-value 0.99, p=0.32).

Conclusion: Self-reported EF was stable over a one-year period in this small cohort of patients with cSLE and controls. Although no significant differences in mean scores for EF were found between cSLE and controls, 59% (versus 40% of HC) had at least mild difficulties in EF. More longitudinal research is needed with longer follow up to identify cognitive function trajectories and at-risk groups for executive dysfunction in cSLE.

Supporting image 1

Supporting image 2


Disclosures: T. El Tal: None; j. ledochowski: None; S. Mossad: None; V. Lishak: None; I. Mohamed: None; J. Law: None; L. Ng: None; P. Moaf: None; A. Jeyanathan: None; A. Davis: None; L. Hiraki: None; D. Levy: None; Z. Touma: AstraZeneca, 2, GSK, 2; N. Cunningham: DoD, 12, DoD Transformative Vision Award (starting Oct 2023) and CARRA Transdisciplinary Research Grant (NCE). I also have other current funding support.; A. Danguecan: None; A. Knight: Pfizer, 6.

To cite this abstract in AMA style:

El Tal T, ledochowski j, Mossad S, Lishak V, Mohamed I, Law J, Ng L, Moaf P, Jeyanathan A, Davis A, Hiraki L, Levy D, Touma Z, Cunningham N, Danguecan A, Knight A. Longitudinal Assessment of Self-reported Executive Function in Youth with Childhood-Onset Lupus [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/longitudinal-assessment-of-self-reported-executive-function-in-youth-with-childhood-onset-lupus/. Accessed .

ACR Meeting Abstracts - https://acrabstracts.org/abstract/longitudinal-assessment-of-self-reported-executive-function-in-youth-with-childhood-onset-lupus/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology